1. Home
  2. TCI vs LUNG Comparison

TCI vs LUNG Comparison

Compare TCI & LUNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TCI
  • LUNG
  • Stock Information
  • Founded
  • TCI 1983
  • LUNG 1995
  • Country
  • TCI United States
  • LUNG United States
  • Employees
  • TCI N/A
  • LUNG N/A
  • Industry
  • TCI Real Estate
  • LUNG Industrial Specialties
  • Sector
  • TCI Finance
  • LUNG Health Care
  • Exchange
  • TCI Nasdaq
  • LUNG Nasdaq
  • Market Cap
  • TCI 239.2M
  • LUNG 248.0M
  • IPO Year
  • TCI N/A
  • LUNG 2020
  • Fundamental
  • Price
  • TCI $28.03
  • LUNG $6.45
  • Analyst Decision
  • TCI
  • LUNG Strong Buy
  • Analyst Count
  • TCI 0
  • LUNG 7
  • Target Price
  • TCI N/A
  • LUNG $13.71
  • AVG Volume (30 Days)
  • TCI 2.8K
  • LUNG 210.4K
  • Earning Date
  • TCI 11-07-2024
  • LUNG 10-28-2024
  • Dividend Yield
  • TCI N/A
  • LUNG N/A
  • EPS Growth
  • TCI N/A
  • LUNG N/A
  • EPS
  • TCI 0.69
  • LUNG N/A
  • Revenue
  • TCI $50,541,000.00
  • LUNG $76,583,000.00
  • Revenue This Year
  • TCI N/A
  • LUNG $22.73
  • Revenue Next Year
  • TCI N/A
  • LUNG $19.02
  • P/E Ratio
  • TCI $40.29
  • LUNG N/A
  • Revenue Growth
  • TCI N/A
  • LUNG 26.26
  • 52 Week Low
  • TCI $26.91
  • LUNG $5.46
  • 52 Week High
  • TCI $43.40
  • LUNG $14.84
  • Technical
  • Relative Strength Index (RSI)
  • TCI 46.65
  • LUNG 32.80
  • Support Level
  • TCI $27.69
  • LUNG $6.56
  • Resistance Level
  • TCI $28.36
  • LUNG $7.47
  • Average True Range (ATR)
  • TCI 0.55
  • LUNG 0.38
  • MACD
  • TCI -0.01
  • LUNG -0.22
  • Stochastic Oscillator
  • TCI 58.95
  • LUNG 2.76

About TCI Transcontinental Realty Investors Inc.

Transcontinental Realty Investors Inc is a fully integrated externally managed real estate company. It operates multifamily and commercial properties throughout the southern United States and also invests in mortgage notes receivable and in the land that is either held for appreciation or development. The company has two business segments: the acquisition, development, ownership, and management of multifamily properties which include the rental of apartments (Residential Segment) and other tenant services, including parking and storage space rental, and the acquisition, development, ownership, and management of commercial properties which are office properties(Commercial Segment). It includes the rental of office space and other tenant services, including parking and storage space rental.

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.

Share on Social Networks: